Tunghai University Institutional Repository:Item 310901/21328
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 21921/27947 (78%)
造访人次 : 4243105      在线人数 : 715
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.128.103.80:8080/handle/310901/21328


    题名: Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
    作者: Long, Y.-Q., Lung, F.-D.T., Roller, P.P.
    贡献者: Department of Chemistry, Tunghai University
    关键词: Adaptor Proteins, Signal Transducing;Amino Acid Sequence;Antineoplastic Agents;GRB2 Adaptor Protein;Ligands;Molecular Sequence Data;Peptides, Cyclic;Phosphorylation;Protein Binding;Protein Conformation;Proteins;src Homology Domains;Structure-Activity Relationship
    日期: 2003
    上传时间: 2013-05-14T09:04:57Z (UTC)
    摘要: Following our earlier work on a phage library derived non-phosphorylated thioether-cyclized peptide inhibitor of Grb2 SH2 domain, a series of small peptide analogues with various cyclization linkage or various ring size were designed and synthesized and evaluated to investigate the optimal conformational constraint for this novel Grb2-SH2 blocker. Our previous SAR studies have indicated that constrained conformation as well as all amino acids except Leu2 and Gly7 in this lead peptide, cyclo(CH 2CO-Glu1-Leu-Tyr-Glu-Asn-Val-Gly-Met-Tyr-Cys 10)-amide (termed G1TE), was necessary for sustenance of the biological activity. In this study, in an effort to derive potent and bioavailable Grb2-SH2 inhibitor with minimal sequence, we undertook a systematic conformational study on this non-phosphorylated cyclic ligand by optimizing the ring linkage, ring configuration and ring size. The polarity and configuration of the cyclization linkage were implicated important in assuming the active conformation. Changing the flexible thioether linkage in G1TE into the relatively rigid sulfoxide linkage secured a 4-fold increase in potency (4, IC50=6.5 μM). However, open chain, shortening or expanding the ring size led to a marked loss of inhibitory activity. Significantly, the introduction of ω-amino carboxylic acid linker in place of three C-terminal amino acids in G1TE can remarkably recover the apparently favorable conformation, which is otherwise lost because of the reduced ring size. This modification, combined with favorable substitutions of Gla for Glu1 and Adi for Glu4 in the resulting six-residue cyclic peptide, afforded peptide 19, with an almost equal potency (19, IC50=23.3 μM) relative to G1TE. Moreover, the lipophilic chain in ω-amino carboxylic acid may confer better cell membrane permeability to 19. These newly developed G1TE analogues with smaller ring size and less peptide character but equal potency can serve as templates to derive potent and specific non-phosphorylated Grb2-SH2 antagonists. ? 2003 Elsevier Ltd. All rights reserved.
    關聯: Bioorganic and Medicinal Chemistry 11 (18) , pp. 3929-3936
    显示于类别:[化學系所] 期刊論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML183检视/开启


    在THUIR中所有的数据项都受到原著作权保护.


    本網站之東海大學機構典藏數位內容,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈